Recommended regimens listed by evidence level and alphabetically for:
Glecaprevir/Pibrentasvir Treatment Failures (All Genotypes), With or Without Compensated Cirrhosisa
|
||
|---|---|---|
| RECOMMENDED | DURATION |
RATING 
|
| Daily fixed-dose combination of glecaprevir (300 mg)/pibrentasvir (120 mg) plus daily sofosbuvir (400 mg) and weight-based ribavirin | 16 weeks | IIa, B |
| Daily fixed-dose combination of sofosbuvir (400 mg)/velpatasvir (100 mg)/voxilaprevir (100 mg) | 12 weeks | IIa, B |
|
|
||
| For patients with compensated cirrhosis, addition of weight-based ribavirin is recommended. | 12 weeks | IIa, C |
| a For decompensated cirrhosis, please refer to the appropriate section. | ||
